Found: 1
Select item for more details and to access through your institution.
CONFIRM: a double-blind, placebo-controlled phase III clinical trial investigating the effect of nivolumab in patients with relapsed mesothelioma: study protocol for a randomised controlled trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article